The NIH-led research response to COVID-19.

Autor: Collins F; National Human Genome Research Institute, Bethesda, MD, USA., Adam S; The Foundation for the National Institutes of Health, North Bethesda, MD, USA., Colvis C; National Center for Advancing Translational Sciences, Bethesda, MD, USA., Desrosiers E; Merck, Rahway, NJ, USA., Draghia-Akli R; The Janssen Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ, USA., Fauci A; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Freire M; The Foundation for the National Institutes of Health, North Bethesda, MD, USA., Gibbons G; National Heart, Lung, and Blood Institute, Bethesda, MD, USA., Hall M; National Center for Advancing Translational Sciences, Bethesda, MD, USA., Hughes E; Teva Pharmaceuticals, Tel Aviv, Israel., Jansen K; Pfizer, New York, NY, USA., Kurilla M; National Center for Advancing Translational Sciences, Bethesda, MD, USA., Lane HC; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Lowy D; National Cancer Institute, Bethesda, MD, USA., Marks P; US Food and Drug Administration, Silver Spring, MD, USA., Menetski J; The Foundation for the National Institutes of Health, North Bethesda, MD, USA., Pao W; Pfizer, New York, NY, USA., Pérez-Stable E; National Institute on Minority Health and Health Disparities, Bethesda, MD, USA., Purcell L; Vir Biotechnology, San Francisco, CA, USA., Read S; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Rutter J; National Center for Advancing Translational Sciences, Bethesda, MD, USA., Santos M; The Foundation for the National Institutes of Health, North Bethesda, MD, USA., Schwetz T; Office of the Director, National Institutes of Health, Bethesda, MD, USA., Shuren J; US Food and Drug Administration, Silver Spring, MD, USA., Stenzel T; US Food and Drug Administration, Silver Spring, MD, USA., Stoffels P; Galapagos, Mechelen, Belgium., Tabak L; Office of the Director, National Institutes of Health, Bethesda, MD, USA., Tountas K; The Foundation for the National Institutes of Health, North Bethesda, MD, USA., Tromberg B; National Institute of Biomedical Imaging and Bioengineering, Bethesda, MD, USA., Wholley D; The Foundation for the National Institutes of Health, North Bethesda, MD, USA., Woodcock J; US Food and Drug Administration, Silver Spring, MD, USA., Young J; Roche, Basel, Switzerland.

Publikováno v: Science (New York, N.Y.) [Science] 2023 Feb 03; Vol. 379 (6631), pp. 441-444. Date of Electronic Publication: 2023 Feb 02.

¿A QUÉ "EVIDENCIA" SE REFIERE LA MEDICINA BASADA EN LA EVIDENCIA (MBE)?

Autor: Torres, Karina Ordóñez¹ kordonezt@uft.edu, Barrera, Jorge Martínez²

Publikováno v: Acta Bioéthica. Oct2024, Vol. 30 Issue 2, p245-252. 8p.

Covid-19 Molecular Diagnostic Testing - Lessons Learned.

Autor: Shuren J; From the Food and Drug Administration, Silver Spring, MD., Stenzel T; From the Food and Drug Administration, Silver Spring, MD.

Publikováno v: The New England journal of medicine [N Engl J Med] 2020 Oct 22; Vol. 383 (17), pp. e97. Date of Electronic Publication: 2020 Sep 09.

Limitations of NHIC claim code-based surveillance and the necessity of UDI implementation in Korea.

Autor: Choi, Sooin¹ (AUTHOR), Kim, Jin Kuk² (AUTHOR), Lee, Jinhyoung³ (AUTHOR), Choi, Soo Jeong² (AUTHOR) crystal@schmc.ac.kr, Lee, You Kyoung¹ (AUTHOR) cecilia@schmc.ac.kr

Publikováno v: Scientific Reports. 9/9/2024, Vol. 14 Issue 1, p1-10. 10p.

Strengthening the Evidence Base for Pediatric Medical Devices Using Real-World Data.

Autor: Fleurence RL; Medical Device Innovation Consortium, Arlington, VA. Electronic address: rfleurence@mdic.org., Forrest CB; Children's Hospital of Philadelphia, Philadelphia, PA., Shuren J; US Food and Drug Administration, Silver Spring, MD.

Publikováno v: The Journal of pediatrics [J Pediatr] 2019 Nov; Vol. 214, pp. 209-211. Date of Electronic Publication: 2019 Aug 01.